NOTCH1 c.970_971del ;(p.V324Qfs*6)

Variant ID: 9-139413170-GAC-G

NM_017617.3(NOTCH1):c.970_971del;(p.V324Qfs*6)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Neuro-Oncology
Thomas, Alissa A AA; Abrey, Lauren E LE; Terziev, Robert R; Raizer, Jeffrey J; Martinez, Nina L NL; Forsyth, Peter P; Paleologos, Nina N; Matasar, Matthew M; Sauter, Craig S CS; Moskowitz, Craig C; Nimer, Stephen D SD; DeAngelis, Lisa M LM; Kaley, Thomas T; Grimm, Sean S; Louis, David N DN; Cairncross, J Gregory JG; Panageas, Katherine S KS; Briggs, Samuel S; Faivre, Geraldine G; Mohile, Nimish A NA; Mehta, Jayesh J; Jonsson, Philip P; Chakravarty, Debyani D; Gao, Jianjiong J; Schultz, Nikolaus N; Brennan, Cameron W CW; Huse, Jason T JT; Omuro, Antonio A
Publication Date: 2017-10-01

Variant appearance in text: NOTCH1: V324Qfs*6
PubMed Link: 28472509
Variant Present in the following documents:
  • Main text
View BVdb publication page